Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV – Get Free Report) was the recipient of a significant drop in short interest in January. As of January 15th, there was short interest totaling 182 shares, a drop of 55.6% from the December 31st total of 410 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average trading volume of 905 shares, the days-to-cover ratio is currently 0.2 days. Based on an average trading volume of 905 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.0% of the company’s stock are sold short.
Mosaic ImmunoEngineering Stock Down 13.8%
Shares of CPMV traded down $0.10 during mid-day trading on Thursday, hitting $0.60. 3,200 shares of the company’s stock were exchanged, compared to its average volume of 636. The stock has a market cap of $4.36 million, a price-to-earnings ratio of -6.69 and a beta of -0.82. The firm has a fifty day moving average of $0.50 and a two-hundred day moving average of $0.56. Mosaic ImmunoEngineering has a twelve month low of $0.25 and a twelve month high of $1.05.
Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) last issued its quarterly earnings data on Wednesday, November 19th. The company reported ($0.02) earnings per share (EPS) for the quarter.
Mosaic ImmunoEngineering Company Profile
Mosaic ImmunoEngineering (OTCMKTS:CPMV) is a development-stage biotechnology company focused on advancing immunotherapies and vaccine candidates through its proprietary nanoparticle platform. The company leverages virus-like particles derived from the cowpea mosaic virus (CPMV) to serve as both antigen carriers and immune stimulators, aiming to enhance the magnitude and durability of immune responses. By engineering these plant-based VLPs to display target antigens or adjuvant properties, Mosaic ImmunoEngineering seeks to create differentiated candidates for oncology indications and infectious disease prevention.
Operating out of the United States, Mosaic ImmunoEngineering is currently in preclinical stages of development.
Featured Articles
- Five stocks we like better than Mosaic ImmunoEngineering
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
